Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -42.02% is in line with its 5-year average of -43.60%, near the high end of its 5-year range (-98.06%–-23.09%).
As of the fiscal period ended Tuesday, June 30, 2026. 37.89% above its 12-month average of -67.66%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -42.02%.
RETURN ON INVESTED CAPITAL (ROIC)
-42.02%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-67.66%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-55.33%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-43.60%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+37.89%
CURRENT VS 3Y AVG
+24.05%
CURRENT VS 5Y AVG
+3.62%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.73%
median of 621 covered companies
CURRENT VS SECTOR MEDIAN
-28.40%
vs the sector median at left
Aura Biosciences, Inc.
Market Cap
$642.86M
Return on Invested Capital (ROIC)
-42.02%
TTM Avg
-67.66%
3Y Avg
-55.33%
5Y Avg
-43.60%
Market Cap
$640.05M
Return on Invested Capital (ROIC)
-17.48%
TTM Avg
-24.56%
3Y Avg
-18.89%
5Y Avg
-16.21%
Market Cap
$637.30M
Return on Invested Capital (ROIC)
-26.94%
TTM Avg
-40.40%
3Y Avg
-38.31%
5Y Avg
-45.27%
Market Cap
$665.40M
Return on Invested Capital (ROIC)
1.97%
TTM Avg
18.16%
3Y Avg
11.04%
5Y Avg
1.26%
Market Cap
$665.48M
Return on Invested Capital (ROIC)
-44.30%
TTM Avg
-32.94%
3Y Avg
-36.44%
5Y Avg
-31.30%
Market Cap
$609.24M
Return on Invested Capital (ROIC)
-20.75%
TTM Avg
-20.15%
3Y Avg
-33.64%
5Y Avg
-24.57%
Market Cap
$671.29M
Return on Invested Capital (ROIC)
-73.27%
TTM Avg
-60.64%
3Y Avg
-63.77%
5Y Avg
-62.42%
Market Cap
$622.01M
Return on Invested Capital (ROIC)
-47.96%
TTM Avg
-47.20%
3Y Avg
-41.20%
5Y Avg
-37.18%
Market Cap
$682.40M
Return on Invested Capital (ROIC)
-101.43%
TTM Avg
-70.16%
3Y Avg
-61.78%
5Y Avg
-52.46%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aura Biosciences, Inc. (AURA) | $642.86M | -42.02% | -67.66% | -55.33% | -43.60% |
| OmniAb, Inc. (OABI)vs › | $640.05M | -17.48% | -24.56% | -18.89% | -16.21% |
| Climb Bio, Inc. (CLYM)vs › | $637.30M | -26.94% | -40.40% | -38.31% | -45.27% |
| MiMedx Group, Inc. (MDXG)vs › | $665.40M | 1.97% | 18.16% | 11.04% | 1.26% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $665.48M | -44.30% | -32.94% | -36.44% | -31.30% |
| AngioDynamics, Inc. (ANGO)vs › | $609.24M | -20.75% | -20.15% | -33.64% | -24.57% |
| Helus Pharma Inc. (HELP)vs › | $671.29M | -73.27% | -60.64% | -63.77% | -62.42% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $622.01M | -47.96% | -47.20% | -41.20% | -37.18% |
| Annexon, Inc. (ANNX)vs › | $682.40M | -101.43% | -70.16% | -61.78% | -52.46% |
| Fulgent Genetics, Inc. (FLGT)vs › | $601.74M | -11.80% | -7.26% | -5.22% | 9.70% |
ROIC
-42.0%
ROE
-41.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -42.02% |
| 2026-03-31 | -98.06% |
| 2025-12-31 | -74.67% |
| 2025-09-30 | -66.22% |
| 2025-06-30 | -57.34% |
| 2025-03-31 | -71.79% |
| 2024-12-31 | -57.35% |
| 2024-09-30 | -48.83% |
| 2024-06-30 | -43.49% |
| 2024-03-31 | -38.52% |
| 2023-12-31 | -35.02% |
| 2023-09-30 | -46.08% |
| 2023-06-30 | -39.92% |
| 2023-03-31 | -33.82% |
| 2022-12-31 | -28.24% |
| 2022-09-30 | -40.78% |
| 2022-06-30 | -36.49% |
| 2022-03-31 | -29.79% |
| 2021-12-31 | -23.09% |
| 2021-09-30 | -33.62% |
| 2021-06-30 | -24.93% |
| 2021-03-31 | -20.21% |
| 2020-12-31 | -114.12% |
